Department of Cardiothoracic Surgery, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK -
Department of Cardiothoracic Surgery, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
Minerva Surg. 2022 Dec;77(6):542-549. doi: 10.23736/S2724-5691.22.09314-5. Epub 2022 Mar 1.
Surgical repair of tracheobronchial tree injuries is challenging due to the difficulties associated with providing perioperative ventilatory support. Veno-venous extracorporeal membrane oxygenation (V-V ECMO) is a recognized treatment modality for managing respiratory failure. Its use has expanded to include offering respiratory support for patients requiring surgery on the tracheobronchial tree. This study presents our experience with V-V ECMO support for elective and emergency surgery for acquired and iatrogenic tracheobronchial pathology.
A retrospective review of our single-center experience of surgical tracheobronchial repairs where V-V ECMO was employed between 2017 and 2020 was undertaken. Preoperative patient characteristics, intraoperative findings, details of ECMO support and postoperative outcomes were collected and analyzed.
Five patients underwent surgery with V-V ECMO support during the study period. Indications for surgery included repair of iatrogenic tracheal tear (N.=2), repair of iatrogenic gastro-bronchial fistula (N.=1), elective tracheoplasty (N.=1) and elective resection of tracheal tumor (N.=1). The median duration of V-V ECMO was 17 hours (range: 4-543 hours), and the median postoperative length of stay was 9 days (range: 7-19 days). In-hospital and 90-day mortality were both 0% (N.=0). Postoperative complications included reoperation for bleeding (N.=1) and thrombotic complications (N.=2).
We have shown how V-V ECMO can be safely utilized to manage patients with a range of tracheobronchial injuries with low rates of postoperative morbidity. Acceptable postoperative outcomes can be achieved for this cohort of clinically complex patients when treatment is provided with a multidisciplinary team approach in high-volume specialist centers.
由于提供围手术期通气支持存在困难,因此气管支气管树损伤的外科修复具有挑战性。静脉-静脉体外膜肺氧合(V-V ECMO)是一种公认的治疗呼吸衰竭的方法。其用途已扩展到包括为需要气管支气管树手术的患者提供呼吸支持。本研究介绍了我们在 2017 年至 2020 年期间使用 V-V ECMO 为获得性和医源性气管支气管病变的择期和急诊手术提供支持的经验。
对我们在单中心进行的 V-V ECMO 支持下进行的外科气管支气管修复手术的经验进行了回顾性分析。收集并分析了术前患者特征、术中发现、ECMO 支持的详细信息和术后结果。
在研究期间,有 5 名患者在手术中接受了 V-V ECMO 支持。手术指征包括修复医源性气管撕裂(N=2)、修复医源性胃-支气管瘘(N=1)、择期气管成形术(N=1)和择期切除气管肿瘤(N=1)。V-V ECMO 的中位持续时间为 17 小时(范围:4-543 小时),术后中位住院时间为 9 天(范围:7-19 天)。院内和 90 天死亡率均为 0%(N=0)。术后并发症包括出血再手术(N=1)和血栓并发症(N=2)。
我们已经证明,V-V ECMO 可安全用于治疗多种气管支气管损伤,术后发病率低。在高容量专科中心,多学科团队方法为这组临床复杂患者提供治疗时,可以实现可接受的术后结果。